Skip to main content

Table 2 Lipid and glucose parameters for before and 1 – 8 h after loading with test meal

From: Fasting remnant lipoproteins can predict postprandial hyperlipidemia

A. All participants

Elapsed time (h)

  

0

1

2

4

6

8

TC

(mg/dL)

182.4 ± 32.8

180.2 ± 32.8

178.2 ± 31.3

180.4 ± 30.1

184.0 ± 31.6

188.2 ± 32.5

LDL-C

(mg/dL)

98.5 ± 26.1

96.3 ± 25.5

95.6 ± 25.5

96.7 ± 24.7

99.8 ± 25.6

102.1 ± 26.2

HDL-C

(mg/dL)

70.1 ± 15.4

68.3 ± 15.4

66.2 ± 14.1

68.3 ± 15.0

70.2 ± 15.7

72.0 ± 16.0

Sd-LDL-C

(mg/dL)

22.4 ± 12.1

19.8 ± 8.8

18.8 ± 8.5

18.6 ± 7.1

18.6 ± 7.1

19.0 ± 7.0

OxLDL

(U/mL)

7.38 ± 4.96

7.04 ± 4.98

7.25 ± 5.74

7.41 ± 5.53

7.71 ± 5.41

8.38 ± 5.46

TG

(mg/dL)

69.8 ± 31.2

92.1 ± 41.0*

103.9 ± 51.4

72.9 ± 40.4

70.7 ± 34.3

53.9 ± 23.8

Non-HDL-C

(mg/dL)

112.3 ± 30.1

112.0 ± 29.9

112.0 ± 29.3

112.0 ± 28.4

113.8 ± 28.7

116.3 ± 29.4

RemL-C

(mg/dL)

3.51 ± 1.84

4.35 ± 2.11

4.29 ± 2.46

3.90 ± 2.38

3.22 ± 1.61

2.98 ± 1.40

RLP-C

(mg/dL)

3.20 ± 1.30

4.22 ± 1.91*

5.01 ± 2.42

3.88 ± 1.94

3.03 ± 1.02

2.82 ± 0.88

RLP-TG

(mg/dL)

16.3 ± 4.0

25.5 ± 14.4

32.6 ± 21.8

21.1 ± 12.3

15.8 ± 3.4

15.3 ± 2.0

ApoA-I

(mg/dL)

161.2 ± 26.6

159.8 ± 27.3

158.7 ± 25.2

160.3 ± 25.2

163.3 ± 26.4

165.7 ± 27.0

ApoA-II

(mg/dL)

37.6 ± 6.0

37.3 ± 6.2

36.8 ± 6.0

37.4 ± 5.9

37.7 ± 5.9

38.4 ± 6.1

ApoB

(mg/dL)

66.6 ± 15.3

65.7 ± 15.1

65.0 ± 14.5

66.2 ± 14.5

67.9 ± 14.8

69.3 ± 15.2

ApoC-II

(mg/dL)

3.2 ± 1.2

3.3 ± 1.2

3.3 ± 1.2

3.3 ± 1.2

3.3 ± 1.1

3.3 ± 1.1

ApoC-III

(mg/dL)

9.5 ± 2.4

9.8 ± 2.5

9.4 ± 2.3

9.2 ± 2.2

9.0 ± 2.1

9.0 ± 2.2

ApoE

(mg/dL)

4.3 ± 1.1

4.3 ± 1.1

4.3 ± 1.0

4.2 ± 1.1

4.1 ± 1.0

4.2 ± 1.1

Non-HDL-C/HDL-C

 

1.70 ± 0.73

1.75 ± 0.75

1.80 ± 0.75

1.75 ± 0.76

1.73 ± 0.74

1.72 ± 0.73

LDL-C/HDL-C

 

1.50 ± 0.60

1.50 ± 0.61

1.52 ± 0.61

1.50 ± 0.61

1.51 ± 0.60

1.50 ± 0.60

ApoB/apoA-I

 

0.43 ± 0.13

0.42 ± 0.13

0.42 ± 0.13

0.43 ± 0.13

0.43 ± 0.13

0.43 ± 0.13

Non-HDL-C/apo B

 

1.67 ± 0.10

1.69 ± 0.10

1.71 ± 0.11

1.68 ± 0.10

1.67 ± 0.10

1.67 ± 0.10

TG/apoB

 

1.06 ± 0.44

1.41 ± 0.56§

1.61 ± 0.71

1.25 ± 0.61

0.93 ± 0.40

0.79 ± 0.32

Plasma glucose

 

(mg/dL)

89.9 ± 5.7

96.9 ± 20.0§

87.5 ± 10.8

87.6 ± 4.9

88.1 ± 5.7

Insulin

 

(μU/mL)

5.6 ± 2.4

42.4 ± 24.6

18.5 ± 14.1

5.0 ± 2.2

4.2 ± 2.1

B. Men

       

TC

 

(mg/dL)

183.1 ± 33.8

181.4 ± 34.5

180.0 ± 33.3

182.4 ± 32.5

185.0 ± 33.2

LDL-C

 

(mg/dL)

101.1 ± 28.2

99.0 ± 27.5

99.3 ± 27.7

99.8 ± 26.9

102.7 ± 27.8

HDL-C

 

(mg/dL)

66.3 ± 16.7

64.7 ± 17.4

62.5 ± 15.5

65.1 ± 17.2

66.5 ± 17.4

Sd-LDL-C

 

(mg/dL)

23.9 ± 11.0

22.2 ± 10.2

21.4 ± 9.5

20.4 ± 9.0

19.8 ± 8.0

OxLDL

 

(U/mL)

7.98 ± 5.48

7.91 ± 5.54

8.12 ± 6.19

8.32 ± 6.11

8.70 ± 6.22

TG

 

(mg/dL)

78.9 ± 36.0

106.3 ± 45.1

119.5 ± 58.9

94.8 ± 51.2

68.6 ± 33.7

Non-HDL-C

 

(mg/dL)

116.8 ± 32.5

116.8 ± 32.2

117.5 ± 31.8

117.3 ± 31.1

118.5 ± 31.2

RemL-C

 

(mg/dL)

4.08 ± 2.13

4.99 ± 2.42

5.16 ± 2.81

4.69 ± 2.80

3.67 ± 1.91

RLP-C

 

(mg/dL)

3.62 ± 1.51

5.00 ± 2.03*

5.82 ± 2.76

4.53 ± 2.23

3.31 ± 1.13

RLP-TG

 

(mg/dL)

17.3 ± 5.1

30.0 ± 16.7§

37.8 ± 26.2

24.7 ± 15.2

16.4 ± 4.5

ApoA-I

 

(mg/dL)

155.7 ± 29.2

154.4 ± 29.9

154.3 ± 28.7

155.2 ± 29.0

157.9 ± 29.4

ApoA-II

 

(mg/dL)

33.8 ± 6.7

38.7 ± 6.8

38.4 ± 6.6

38.8 ± 6.5

39.1 ± 6.7

ApoB

 

(mg/dL)

68.8 ± 16.3

68.3 ± 16.3

67.5 ± 15.6

68.8 ± 15.8

70.5 ± 16.0

ApoC-II

 

(mg/dL)

3.5 ± 1.1

3.6 ± 1.1

3.6 ± 1.2

3.6 ± 1.2

3.6 ± 1.1

ApoC-III

 

(mg/dL)

9.7 ± 2.6

10.2 ± 2.8

9.8 ± 2.7

9.5 ± 2.5

9.2 ± 2.3

ApoE

 

(mg/dL)

4.1 ± 1.1

4.1 ± 1.1

4.2 ± 1.0

4.0 ± 1.1

3.9 ± 1.0

Non-HDL-C/HDL-C

 

1.90 ± 0.85

1.96 ± 0.88

2.02 ± 0.87

1.96 ± 0.89

1.94 ± 0.86

1.92 ± 0.86

LDL-C/HDL-C

 

1.64 ± 0.71

1.66 ± 0.72

1.70 ± 0.70

1.66 ± 0.72

1.67 ± 0.71

1.66 ± 0.71

ApoB/apoA-I

 

0.46 ± 0.15

0.46 ± 0.15

0.46 ± 0.15

0.46 ± 0.16

0.46 ± 0.15

0.46 ± 0.15

Non-HDL-C/apo B

 

1.69 ± 0.10

1.70 ± 0.11

1.73 ± 0.12

1.70 ± 0.11

1.67 ± 0.10

1.68 ± 0.11

TG/apoB

 

1.17 ± 0.52

1.58 ± 0.63

1.79 ± 0.84

1.41 ± 0.73

1.00 ± 0.49

0.86 ± 0.39

Plasma glucose

(mg/dL)

91.1 ± 5.9

97.7 ± 19.9

85.7 ± 9.7

89.2 ± 4.6

88.7 ± 5.9

87.7 ± 5.9

Insulin

(μU/mL)

5.0 ± 2.1

33.6 ± 13.7

11.6 ± 7.4

4.5 ± 2.0

3.8 ± 2.3

3.7 ± 1.8

C. Women

       

TC

(mg/dL)

181.4 ± 32.3

178.6 ± 31.3

175.7 ± 29.1

177.6 ± 27.1

182.7 ± 30.0

186.5 ± 29.6

LDL-C

(mg/dL)

95.1 ± 23.3

92.6 ± 22.6

90.6 ± 21.8

92.5 ± 21.4

95.7 ± 22.2

97.7 ± 22.1

HDL-C

(mg/dL)

75.3 ± 12.0

73.2 ± 10.9

71.3 ± 10.3

72.8 ± 10.4

75.4 ± 11.6

77.0 ± 11.6

Sd-LDL-C

(mg/dL)

20.3 ± 13.6

16.5 ± 4.9

15.3 ± 5.3

16.1 ± 4.6

16.8 ± 5.5

16.7 ± 5.2

OxLDL

(U/mL)

6.55 ± 4.15

5.86 ± 3.91

6.06 ± 4.99

6.17 ± 4.48

6.37 ± 3.83

6.92 ± 4.10

TG

(mg/dL)

57.3 ± 16.8

72.7 ± 24.6

82.6 ± 28.3

63.7 ± 17.0

52.8 ± 12.4

45.2 ± 10.3

Non-HDL-C

(mg/dL)

106.1 ± 25.9

105.4 ± 25.8

104.4 ± 24.2

104.8 ± 23.2

107.3 ± 24.3

109.5 ± 23.9

RemL-C

(mg/dL)

2.73 ± 0.95

3.47 ± 1.16

3.11 ± 1.13

2.83 ± 0.95

2.60 ± 0.77

2.45 ± 0.69

RLP-C

(mg/dL)

2.62 ± 0.60

3.16 ± 1.06

3.90 ± 1.22

2.98 ± 0.88

2.66 ± 0.72

2.52 ± 0.54

RLP-TG

(mg/dL)

15

19.4 ± 7.0

25.5 ± 11.0

16.2 ± 2.1

15.0 ± 0.2

15

ApoA-I

(mg/dL)

168.7 ± 21.0

167.3 ± 21.8

164.8 ± 18.5

167.3 ± 17.3

170.7 ± 20.1

172.7 ± 20.3

ApoA-II

(mg/dL)

36.0 ± 4.6

35.4 ± 4.7

34.6 ± 4.4

35.3 ± 4.3

35.8 ± 4.1

36.5 ± 4.5

ApoB

(mg/dL)

63.7 ± 13.6

62.2 ± 12.9

61.5 ± 12.5

62.6 ± 12.2

64.4 ± 12.6

65.8 ± 12.4

ApoC-II

(mg/dL)

2.8 ± 1.1

2.9 ± 1.1

2.9 ± 1.1

2.9 ± 1.0

2.9 ± 1.0

2.9 ± 1.1

ApoC-III

(mg/dL)

9.1 ± 2.0

9.3 ± 2.0

8.9 ± 1.7

8.8 ± 1.6

8.6 ± 1.8

8.7 ± 1.8

ApoE

(mg/dL)

4.7 ± 1.0

4.6 ± 1.1

4.5 ± 1.1

4.5 ± 1.1

4.5 ± 1.1

4.6 ± 1.1

Non-HDL-C/HDL-C

 

1.43 ± 0.38

1.46 ± 0.40

1.48 ± 0.39

1.47 ± 0.40

1.45 ± 0.39

1.45 ± 0.37

LDL-C/HDL-C

 

1.28 ± 0.33

1.28 ± 0.33

1.29 ± 0.33

1.29 ± 0.34

1.29 ± 0.33

1.29 ± 0.32

ApoB/apoA-I

 

0.38 ± 0.08

0.37 ± 0.08

0.38 ± 0.08

0.38 ± 0.08

0.38 ± 0.08

0.38 ± 0.08

Non-HDL-C/apo B

 

1.66 ± 0.11

1.68 ± 0.09

1.69 ± 0.11

1.67 ± 0.08

1.66 ± 0.10

1.66 ± 0.10

TG/apoB

 

0.92 ± 0.26

1.17 ± 0.32

1.36 ± 0.40

1.04 ± 0.29

0.84 ± 0.22

0.70 ± 0.17

Plasma glucose

(mg/dL)

88.3 ± 5.2

95.8 ± 20.6

89.9 ± 12.1

85.5 ± 5.0

87.1 ± 5.1

86.5 ± 5.7

Insulin

(μU/mL)

6.5 ± 2.6

54.1 ± 31.1

27.9 ± 15.7

5.6 ± 2.4

4.8 ± 1.8

3.9 ± 1.5

  1. Apo, apolipoprotein; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; OxLDL, oxidized LDL; RemL-C, remnant lipoprotein cholesterol measured using “MetaboLead RemL-C”; RLP-C, remnant-like particle-cholesterol measured with “JIMRO II”; RLP-TG, remnant-like particle-triglycerides; Sd-LDL-C, small, dense-LDL cholesterol; TC, total cholesterol; TG, triglycerides. TG, RemL-C, RLP-C, RLP-TG, and TG/apoB were transformed into logarithmic values. Values are expressed as means ± SD. *p < 0.05, p < 0.005, p < 0.0001, §p < 0.01, p < 0.001, vs. time 0 (repeated ANOVA with Dunnett’s test).